Protia Inc. (KOSDAQ:303360)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,990.00
0.00 (0.00%)
At close: Apr 28, 2026
51.90%
Market Cap 64.26B
Revenue (ttm) 15.12B
Net Income (ttm) 4.47B
Shares Out 12.88M
EPS (ttm) 347.00
PE Ratio 14.38
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 15,141
Average Volume 40,277
Open 4,980.00
Previous Close 4,990.00
Day's Range 4,955.00 - 5,030.00
52-Week Range 2,935.00 - 6,890.00
Beta 0.22
RSI 54.83
Earnings Date n/a

About Protia

Protia Inc. manufactures and sells in vitro diagnostic medical devices in South Korea. It offers allergy, animal diagnosis, autoimmune, antibiotic susceptibility, POCT, cancer, and related instrument products, as well as protein analysis, LC-MS/MS, characterization analysis, and custom protein services. The company was formerly known as ProteomeTech Inc. and changed its name to Protia Inc. in November 2023. Protia Inc. was founded in 2000 and is headquartered in Seoul, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2000
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 303360
Full Company Profile

Financial Performance

In 2025, Protia's revenue was 15.12 billion, an increase of 43.80% compared to the previous year's 10.51 billion. Earnings were 4.47 billion, an increase of 83.09%.

Financial Statements

News

There is no news available yet.